Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Cash from Discontinued Operations (2023 - 2024)

Historic Cash from Discontinued Operations for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q4 2024 value amounting to -$20.0 million.

  • Indivior Pharmaceuticals' Cash from Discontinued Operations rose 9288.26% to -$20.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$272.0 million, marking a year-over-year change of. This contributed to the annual value of $21.0 million for FY2024, which is 10666.67% up from last year.
  • Indivior Pharmaceuticals' Cash from Discontinued Operations amounted to -$20.0 million in Q4 2024, which was up 9288.26% from $8.0 million recorded in Q3 2024.
  • Indivior Pharmaceuticals' Cash from Discontinued Operations' 5-year high stood at $21.0 million during Q3 2023, with a 5-year trough of -$281.0 million in Q4 2023.